# Sporozoite Challenge of Polyprotein Vaccinees

> **NCT00375128** · PHASE1,PHASE2 · COMPLETED · sponsor: **European Vaccine Initiative** · enrollment: 26 (—)

## Conditions studied

- Malaria, Falciparum
- Malaria

## Interventions

- **BIOLOGICAL:** FP9-PP (FP9 polyprotein)
- **BIOLOGICAL:** MVA-PP (Modified Virus Ankara polyprotein)

## Key facts

- **NCT ID:** NCT00375128
- **Lead sponsor:** European Vaccine Initiative
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** —
- **Final completion:** 2007-04
- **Target enrollment:** 26 (—)
- **Last updated:** 2007-10-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00375128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00375128, "Sporozoite Challenge of Polyprotein Vaccinees". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00375128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*